As a company that specializes in drug information, DrugBank always tries to
remain informed about novel treatments, drug approvals, and drugs that are
impacting global health. At the top of our minds lately is Zolgensma
[https://www.drugbank.ca/drugs/DB15528] (Onasemnogene abeparvovec), a gene
therapy indicated for the treatment
